| 臺大學術典藏 |
2018-09-10T03:28:36Z |
High E gate dielectrics Gd2O3 and Y2O3 for silicon
|
Boone, T; Krajewski, JJ; Sergent, AM; Rosamilia, JM; MINGHWEI HONG; Mannaerts, JP; Kwo, J; Hong, M; Kortan, AR; Queeney, KT; Chabal, YJ |
| 國立交通大學 |
2019-12-13T01:12:17Z |
High Effectiveness in Actions of Carfilzomib on Delayed-Rectifier K+ Current and on Spontaneous Action Potentials
|
So, Edmund Cheung; Liu, Ping-Yen; Lee, Chien-Ching; Wu, Sheng-Nan |
| 國立成功大學 |
2019-10-7 |
High Effectiveness in Actions of Carfilzomib on Delayed-Rectifier K+ Current and on Spontaneous Action Potentials
|
So;Cheung, Edmund;Liu;Ping-Yen;Lee;Chien-Ching;Wu;Sheng-Nan |
| 國家衛生研究院 |
2014-09 |
High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells
|
So, EC;Lo, YC;Chen, LT;Kao, CA;Wu, SN |
| 國立成功大學 |
2014-09-05 |
High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells
|
So, Edmund Cheung; Lo, Yi-Ching; Chen, Li-Tzong; Kao, Chin-An; Wu, Sheng-Nan |
| 國立成功大學 |
2020-02 |
High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits I-K(M) or I-h
|
Lu;Te-Ling;Gao;Zi-Han;Li;Shih-Wei;Wu;Sheng-Nan |
| 國立成功大學 |
2020 |
High efficacy by GAL-021: A known intravenous peripheral chemoreceptor modulator that suppresses BKca-channel activity and inhibits Ik(m) or Ih
|
Lu, T.-L.;Gao, Z.-H.;Li, S.-W.;Wu, S.-N. |
| 中國醫藥大學 |
2010-03 |
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria
|
沈光漢; 吳柏達(Bo-Da Wu); 胡小婷(Shiau-Ting Hu); 林進福(Chen-Fu Lin); 吳崑銘(Kun-Ming Wu); 陳健華(Jiann-Hwa Chen)* |
| 高雄醫學大學 |
2008 |
High efficacy of erlotinib in Taiwanese NSCLC patients in an exp;ed access program study previously treated with chemotherapy
|
黃明賢; Perng RP;Yang CH;Chen YM;Chang GC;Lin MC;Hsieh RK;Chu NM;Lai RS;Su WC;Tsao CJ;Hsia TC;Chen HC;Chen CH;Huang MS;Wang JL;Ho ML;Chung CY;Yu CJ;Chang WC;Kuo HP;Yu CT;Lin ZZ;Kao WY. |
| 臺大學術典藏 |
2022-06-27T07:07:55Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; CHONG-JEN YU; Chang W.-C.; Kuo H.-P.; Yu C.-T.; Lin Z.-Z.; Kao W.-Y. |
